Herpes Virus Infection in Lung Transplantation: Diagnosis, Treatment and Prevention Strategies
Authors:
- Filippo PatruccoFPFilippo Patrucco
- Antonio CurtoniACAntonio Curtoni
- Francesca SidotiFSFrancesca Sidoti
- Elisa ZanottoEZElisa Zanotto
- Alessandro BondiABAlessandro Bondi
- Carlo AlberaCACarlo Albera
- Massimo BoffiniMBMassimo Boffini
- Rossana CavalloRCRossana Cavallo
- Cristina CostaCCCristina Costa
- Paolo SolidoroPSPaolo Solidoro
Open Access
Abstract
Lung transplantation is an ultimate treatment option for some end-stage lung diseases; due to the intense immunosuppression needed to reduce the risk of developing acute and chronic allograft failure, infectious complications are highly incident. Viral infections represent nearly 30% of all infectious complications, with herpes viruses playing an important role in the development of acute and chronic diseases. Among them, cytomegalovirus (CMV) is a major cause of morbidity and mortality, being associated with an increased risk of chronic lung allograft failure. Epstein–Barr virus (EBV) is associated with transformation of infected B cells with the development of post-transplantation lymphoproliferative disorders (PTLDs). Similarly, herpes simplex virus (HSV), varicella zoster virus and human herpesviruses 6 and 7 can also be responsible for acute manifestations in lung transplant patients. During these last years, new, highly sensitive and specific diagnostic tests have been developed, and preventive and prophylactic strategies have been studied aiming to reduce and prevent the incidence of these viral infections. In this narrative review, we explore epidemiology, diagnosis and treatment options for more frequent herpes virus infections in lung transplant patients.Keywords
Funding Information
- EU Funding within the MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases (PE00000007)
This publication has 179 references indexed in Scilit:
- The Immune Response to Human CMVFuture Virology, 2012
- Chromosomally integrated human herpesvirus 6: questions and answersReviews in Medical Virology, 2011
- Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysisBMC Pediatrics, 2011
- Herpes zoster incidence in a multicenter cohort of solid organ transplant recipientsTransplant Infectious Disease, 2011
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Strategies for Herpes Zoster Vaccination of Immunocompromised PatientsThe Journal of Infectious Diseases, 2008
- Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigationCritical Care, 2007
- Relationship between Cytomegalovirus DNA Load in Epithelial Lining Fluid and Plasma of Lung Transplant Recipients and Analysis of Coinfection with Epstein-Barr Virus and Human Herpesvirus 6 in the Lung CompartmentJournal of Clinical Microbiology, 2007
- Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative DisordersScience, 1986